{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T14:02:53Z","timestamp":1788357773431,"version":"build-2803163510"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Peripheral neuropathies are traditionally categorized into demyelinating or axonal. It has been proposed that dysfunction at nodal\/paranodal region may be a key for better understanding of pathophysiology in patients with immune mediated neuropathies. In last few years, antibodies targeting node and paranode of myelinated nerves have been increasingly detected in patients with immune mediated neuropathies. These patients have clinical phenotype similar common inflammatory neuropathies like Guillain Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy with some additional atypical neurological and systemic features, and they respond poorly to conventional first line immunotherapies like IVIG. This review summarizes the structure of the node, concept and pathophysiology of nodopathies. We provide an overview of clinical phenotypes in patients with specific nodal\/paranodal antibodies, along with electrophysiological and other diagnostic features and suggest therapeutic line of management based on current evidence.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/aian.aian_382_22","type":"journal-article","created":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T08:29:52Z","timestamp":1659601792000},"page":"1001-1008","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Nodo-paranodopathies"],"prefix":"10.4103","volume":"25","author":[{"given":"Satish V.","family":"Khadilkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Kamat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riddhi","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20240828","first-page":"1168","article-title":"Contributions \u00e0 l'histologie et \u00e0 la physiologie des nerfs p\u00e9riph\u00e9riques","volume":"73","author":"Ranvier","year":"1871","journal-title":"C R Acad Sci"},{"key":"R2-7-20240828","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1113\/jphysiol.1949.sp004335","article-title":"Evidence for saltatory conduction in peripheral myelinated nerve fibres","volume":"108","author":"Huxley","year":"1949","journal-title":"J Physiol"},{"key":"R3-7-20240828","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.clinph.2013.03.025","article-title":"Nodo-paranodopathy: Beyond the demyelinating and axonal classification in anti-ganglioside antibody-mediated neuropathies","volume":"124","author":"Uncini","year":"2013","journal-title":"Clin Neurophysiol"},{"key":"R4-7-20240828","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1136\/jnnp-2014-310097","article-title":"Nodopathies of the peripheral nerve: An emerging concept","volume":"86","author":"Uncini","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R5-7-20240828","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.410330202","article-title":"Molecular dissection of the myelinated axon","volume":"33","author":"Waxman","year":"1993","journal-title":"Ann Neurol"},{"key":"R6-7-20240828","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.semcdb.2010.09.010","article-title":"Composition, assembly, and maintenance of excitable membrane domains in myelinated axons","volume":"22","author":"Rasband","year":"2011","journal-title":"Semin Cell Dev Biol"},{"key":"R7-7-20240828","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0896-6273(01)00296-3","article-title":"Contactin orchestrates assembly of the septate-like junctions at the paranode in myelinated peripheral nerve","volume":"30","author":"Boyle","year":"2001","journal-title":"Neuron"},{"key":"R8-7-20240828","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1083\/jcb.200305018","article-title":"Juxtaparanodal clustering of Shaker-like K+channels in myelinated axons depends on Caspr2 and TAG-1","volume":"162","author":"Poliak","year":"2003","journal-title":"J Cell Biol"},{"key":"R9-7-20240828","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1093\/brain\/awf258","article-title":"Localization of major gangliosides in the PNS: Implications for immune neuropathies","volume":"125","author":"Gong","year":"2002","journal-title":"Brain"},{"key":"R10-7-20240828","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/glia.20503","article-title":"Ganglioside contribute to stability of paranodal junctions and ion channel clusters in myelinated nerve fibers","volume":"55","author":"Susuki","year":"2007","journal-title":"Glia"},{"key":"R11-7-20240828","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/mus.24070","article-title":"Pathophysiology of immune-mediated demyelinating neuropathies-part I: Neuroscience","volume":"48","author":"Franssen","year":"2013","journal-title":"Muscle Nerve"},{"key":"R12-7-20240828","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s12035-008-8036-x","article-title":"Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration","volume":"38","author":"Vosler","year":"2008","journal-title":"Mol Neurobiol"},{"key":"R13-7-20240828","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/ana.410440210","article-title":"IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barr\u00e9 syndrome","volume":"44","author":"Kuwabara","year":"1998","journal-title":"Ann Neurol"},{"key":"R14-7-20240828","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/jnnp-2016-315480","article-title":"Nodes, paranodes and neuropathies","volume":"89","author":"Fehmi","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R15-7-20240828","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","article-title":"Guillain-Barr\u00e9 syndrome","volume":"366","author":"Hughes","year":"2005","journal-title":"Lancet"},{"key":"R16-7-20240828","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1212\/WNL.61.5.617","article-title":"Acute motor conduction block neuropathy Another Guillain-Barr\u00e9 syndrome variant","volume":"61","author":"Capasso","year":"2003","journal-title":"Neurology"},{"key":"R17-7-20240828","doi-asserted-by":"crossref","first-page":"5683","DOI":"10.1038\/ncomms6683","article-title":"A recoverable state of axon injury persists for hours after spinal cord contusion in vivo","volume":"5","author":"Williams","year":"2014","journal-title":"Nat Commun"},{"key":"R18-7-20240828","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.clinph.2012.01.025","article-title":"Electrodiagnostic criteria for Guillain-Barr\u00e8 syndrome: A critical revision and the need for an update","volume":"123","author":"Uncini","year":"2012","journal-title":"Clin Neurophysiol"},{"key":"R19-7-20240828","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/mus.27115","article-title":"Nodal conduction block: A unifying concept","volume":"63","author":"Oh","year":"2021","journal-title":"Muscle Nerve"},{"key":"R20-7-20240828","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1093\/brain\/awq260","article-title":"Conduction block in acute motor axonal neuropathy","volume":"133","author":"Kokubun","year":"2010","journal-title":"Brain"},{"key":"R21-7-20240828","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/jnnp-2011-300309","article-title":"Antiganglioside antibodies are associated with axonal Guillain-Barr\u00e9 syndrome: A Japanese-Italian collaborative study","volume":"83","author":"Sekiguchi","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R22-7-20240828","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrneurol.2011.175","article-title":"Multifocal motor neuropathy: Diagnosis, pathogenesis and treatment strategies","volume":"8","author":"Vlam","year":"2011","journal-title":"Nat Rev Neurol"},{"key":"R23-7-20240828","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/ana.410330204","article-title":"Pathological findings at the site of conduction block in multifocal motor neuropathy","volume":"33","author":"Kaji","year":"1993","journal-title":"Ann Neurol"},{"key":"R24-7-20240828","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/jnen\/63.2.129","article-title":"Multifocal motor neuropathy: Pathologic alterations at the site of conduction block","volume":"63","author":"Taylor","year":"2004","journal-title":"J Neuropathol Exp Neurol"},{"key":"R25-7-20240828","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1093\/brain\/awv054","article-title":"Contactin 1 IgG4 associates to chronic inflammatory demyelinating polyneuropathy with sensory ataxia","volume":"138","author":"Miura","year":"2015","journal-title":"Brain"},{"key":"R26-7-20240828","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1212\/WNL.0000000000002418","article-title":"Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy","volume":"86","author":"Devaux","year":"2016","journal-title":"Neurology"},{"key":"R27-7-20240828","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1212\/WNL.0000000000000205","article-title":"Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg","volume":"82","author":"Querol","year":"2014","journal-title":"Neurology"},{"key":"R28-7-20240828","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/acn3.248","article-title":"Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy","volume":"2","author":"Ogata","year":"2015","journal-title":"Ann Clin Transl Neurol"},{"key":"R29-7-20240828","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1212\/WNL.0b013e3182a1aa9c","article-title":"Anti-neurofascin antibody in patients with combined central and peripheral demyelination","volume":"81","author":"Kawamura","year":"2013","journal-title":"Neurology"},{"key":"R30-7-20240828","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.nmd.2016.10.008","article-title":"Paranodal lesions in chronic inflammatory demyelinating polyneuropathy associated with anti-Neurofascin 155 antibodies","volume":"27","author":"Vallat","year":"2017","journal-title":"Neuromuscul Disorder"},{"key":"R31-7-20240828","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1212\/NXI.0000000000000149","article-title":"Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins","volume":"2","author":"Querol","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"R32-7-20240828","doi-asserted-by":"crossref","first-page":"104360","DOI":"10.1016\/j.neuint.2018.12.011","article-title":"Anti-neurofascin autoantibody and demyelination","volume":"130","author":"Kira","year":"2019","journal-title":"Neurochem Int"},{"key":"R33-7-20240828","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1136\/jnnp-2016-314895","article-title":"Paranodal dissection in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 and anti-contactin-1 antibodies","volume":"88","author":"Koike","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R34-7-20240828","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.clinph.2020.01.013","article-title":"Electrophysiological features of chronic inflammatory demyelinating polyradiculoneuropathy associated with IgG4 antibodies targeting neurofascin 155 or contactin 1 glycoproteins","volume":"131","author":"Kouton","year":"2020","journal-title":"Clin Neurophysiol"},{"key":"R35-7-20240828","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/ana.23794","article-title":"Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy","volume":"73","author":"Querol","year":"2013","journal-title":"Ann Neurol"},{"key":"R36-7-20240828","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1136\/jnnp-2014-309916","article-title":"Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin-1 autoantibodies","volume":"86","author":"Doppler","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R37-7-20240828","doi-asserted-by":"crossref","first-page":"997","DOI":"10.3389\/fneur.2018.00997","article-title":"Chronic inflammatory demyelinating polyneuropathy with concurrent membranous nephropathy: An anti-paranode and podocyte protein antibody study and literature survey","volume":"9","author":"Hashimoto","year":"2018","journal-title":"Front Neurol"},{"key":"R38-7-20240828","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.1002\/mus.26392","article-title":"\u201cNeuro-renal syndrome\u201d related to anti-contactin-1 antibodies","volume":"59","author":"Taieb","year":"2019","journal-title":"Muscle Nerve"},{"key":"R39-7-20240828","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1093\/jnen\/nlw093","article-title":"Contactin-Associated Protein 1 (CNTNAP1) Mutations Induce Characteristic Lesions of the Paranodal Region","volume":"75","author":"Vallat","year":"2016","journal-title":"J Neuropathol Exp Neurol"},{"key":"R40-7-20240828","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/practneurol-2021-002960","article-title":"Nodal and paranodal antibody-associated neuropathies","volume":"21","author":"Fehmi","year":"2021","journal-title":"Pract Neurol"},{"key":"R41-7-20240828","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1136\/jnnp-2021-326343","article-title":"IgG 1 pan-neurofascin antibodies identify a severe yet treatable neuropathy with a high mortality","volume":"92","author":"Fehmi","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R42-7-20240828","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/ng1094-136","article-title":"Episodic ataxia\/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1","volume":"8","author":"Browne","year":"1994","journal-title":"Nat Genet"},{"key":"R43-7-20240828","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1136\/jnnp-2020-324675","article-title":"Isaacs syndrome: The frontier of neurology, psychiatry, immunology and cancer","volume":"91","author":"Park","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R44-7-20240828","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/jnnp-2016-314758","article-title":"Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies","volume":"88","author":"Lang","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R45-7-20240828","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/jns.12089","article-title":"Guillain-Barr\u00e9 syndrome associated with CASPR2 antibodies: Two paediatric cases","volume":"19","author":"Rosch","year":"2014","journal-title":"J Peripher Nerv Syst"},{"key":"R46-7-20240828","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/mus.23851","article-title":"Guillain-Barr\u00e9-like syndrome associated with lung adenocarcinoma and CASPR2 antibodies","volume":"48","author":"T\u00fcz\u00fcn","year":"2013","journal-title":"Muscle Nerve"},{"key":"R47-7-20240828","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.3390\/jcm9072025","article-title":"Immunoadsorption and plasma exchange in seropositive and seronegative immune-mediated neuropathies","volume":"9","author":"Davies","year":"2020","journal-title":"J Clin Med"},{"key":"R48-7-20240828","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/jns.12287","article-title":"Rituximab in chronic inflammatory demyelinating polyradiculoneuropathy with associated diseases","volume":"23","author":"Roux","year":"2018","journal-title":"J Peripher Nerv Syst"},{"key":"R49-7-20240828","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1468-1331.2009.02930.x","article-title":"European Federation of Neurological Societies\/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society \u2013 first revision","volume":"17","author":"Van Den Bergh","year":"2010","journal-title":"Eur J Neurol"},{"key":"R50-7-20240828","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11940-021-00683-3","article-title":"Update on nodopathies of the peripheral nerve","volume":"23","author":"Vizcarra","year":"2021","journal-title":"Curr Treat Options Neurol"},{"key":"R51-7-20240828","first-page":"1184","article-title":"Guillain-Barr\u00e9 Syndrome","volume":"26","author":"Sheikh","year":"2020","journal-title":"Continuum (Minneap Minn"},{"key":"R52-7-20240828","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1474-4422(18)30114-5","article-title":"Safety and efficacy of eculizumab in Guillain-Barr\u00e9 syndrome: A multicentre, double-blind, randomised phase 2 trial","volume":"17","author":"Misawa","year":"2018","journal-title":"Lancet Neurol"}],"container-title":["Annals of Indian Academy of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/aian.aian_382_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:08:21Z","timestamp":1787756901000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aian.aian_382_22"}},"subtitle":["Concepts, Clinical Implications, and Management"],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/aian.aian_382_22","relation":{},"ISSN":["0972-2327"],"issn-type":[{"value":"0972-2327","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]}}}